Log in

ETR:CCAPCorestate Capital Stock Price, Forecast & News

+0.59 (+3.48 %)
(As of 07/10/2020 04:00 PM ET)
Today's Range
Now: €17.53
50-Day Range
MA: €18.53
52-Week Range
Now: €17.53
Volume149,532 shs
Average VolumeN/A
Market Capitalization$376.54 million
P/E Ratio3.87
Dividend Yield13.51%
CORESTATE Capital Holding S.A. is a real estate investment firm specializing in investments in small to medium sized residential portfolios and commercial real estate markets. The firm seeks to invest in an "anti-cyclical" manner in Europe and expand its club-style deals from purely opportunistic to core-plus and value-add investments. The firm offers investment products in real estate funds, co-investments, and club deals. It prefers to invest in Central Europe, Austria, Switzerland, and Germany. CORESTATE Capital Holding S.A. was founded in 2006 and is based in Luxembourg, Luxembourg with additional offices in Zug, Switzerland; London, United Kingdom; Frankfurt, Germany; and Singapore. CORESTATE Capital Holding S.A. operates as a subsidiary of Flygon Holding LLC.
Read More
Corestate Capital logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 3.2Dividend Strength: 2.5Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.22 out of 5 stars

Industry, Sector and Symbol

Industry Real Estate Services
Phone352 26 6372 20



Sales & Book Value

Annual Sales$266.79 million
Cash Flow€4.40 per share
Book Value€31.75 per share



Market Cap$376.54 million
Next Earnings DateN/A
OptionableNot Optionable

Receive CCAP News and Ratings via Email

Sign-up to receive the latest news and ratings for CCAP and its competitors with MarketBeat's FREE daily newsletter.

Corestate Capital (ETR:CCAP) Frequently Asked Questions

How has Corestate Capital's stock been impacted by COVID-19 (Coronavirus)?

Corestate Capital's stock was trading at €38.30 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, CCAP stock has decreased by 54.2% and is now trading at €17.53. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Corestate Capital?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Corestate Capital in the last year. There are currently 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Corestate Capital.

What price target have analysts set for CCAP?

6 equities research analysts have issued 12 month price targets for Corestate Capital's stock. Their forecasts range from €38.00 to €65.00. On average, they expect Corestate Capital's stock price to reach €49.33 in the next year. This suggests a possible upside of 181.4% from the stock's current price. View analysts' price targets for Corestate Capital.

Has Corestate Capital been receiving favorable news coverage?

Media stories about CCAP stock have been trending neutral on Saturday, according to InfoTrie Sentiment Analysis. The research firm scores the sentiment of media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Corestate Capital earned a news impact score of 0.2 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the near term. View the latest news about Corestate Capital.

Who are some of Corestate Capital's key competitors?

What other stocks do shareholders of Corestate Capital own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Corestate Capital investors own include AbbVie (ABBV), Appian (APPN), Alibaba Group (BABA), Delivery Hero (DHER), Enel (ENEL), Engie (ENGI), Alphabet (GOOG), Lloyds Banking Group (LLOY), NuStar Energy (NS) and Omega Healthcare Investors (OHI).

Who are Corestate Capital's key executives?

Corestate Capital's management team includes the following people:
  • Mr. Lars Schnidrig L.L.M., M.B.A., Chairman of Management Board, CEO & CFO (Age 47)
  • Mr. Ralph Winter, Founder & Sr. Advisor
  • Mr. Thomas Landschreiber, Founder, Chief Investment Officer & Member of Management Board (Age 51)
  • Ms. Silke Hechle, Founder
  • Mr. Christine Winter, Founder

What is Corestate Capital's stock symbol?

Corestate Capital trades on the ETR under the ticker symbol "CCAP."

What is Corestate Capital's stock price today?

One share of CCAP stock can currently be purchased for approximately €17.53.

How big of a company is Corestate Capital?

Corestate Capital has a market capitalization of $376.54 million and generates $266.79 million in revenue each year. Corestate Capital employs 675 workers across the globe.

What is Corestate Capital's official website?

The official website for Corestate Capital is www.corestate-capital.ch.

How can I contact Corestate Capital?

The company can be reached via phone at 352 26 6372 20.

This page was last updated on 7/11/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.